Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule belonging to the class of n-acyl-alpha amino acids and derivatives. It is structurally related to bacterial quorum sensing molecules known as N-acyl homoserine lactones (AHLs), specifically the Pseudomonas aeruginosa autoinducer N-(3‑oxododecanoyl) homoserine lactone. These compounds function as signaling molecules in bacterial communication (quorum sensing), regulating gene expression in response to cell population density. The compound itself is experimental and not approved for clinical use; it has been studied primarily for its role in chemical biology and microbiology research related to quorum sensing pathways[1][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-oxo-N-[(3S)-2-oxopyrrolidin-3-yl]dodecanamide.